Table 2.
Previous therapies.
Characteristic | N = 15 |
---|---|
N (%) | |
Previous treatment for advanced disease | |
Number of treatment lines – Median (range) | 2.5 (1–7) |
Hormonal therapy | 6 (40) |
Trastuzumab | 15 (100) |
Capecitabine-lapatinib | 12 (80) |
Lyposomal Anthracyclines | 2 (13.4) |
Taxanes | 7 (47) |
Previous treatment for adjuvant/neoadjuvant therapy | |
Hormonal therapy | 7 (47) |
Trastuzumab | 14 (94) |
Anthracyclines | 9 (60) |
Taxanes | 9 (60) |
CMF | 2 (13.4) |
Carboplatin | 1 (6.7) |
CMF, Cyclophosphamide, Methotrexate, Fluorouracil.